| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
5 companies
Timothy M Shannon last filed a Form 4 in June 2023, as Director at CTMX. The filings on record cover 5 companies. From October 2015 to September 2021, the filings on record show 8 open-market purchases and 19 sales. Timothy M Shannon's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Timothy M Shannon's trades have earned a strong insider score of 82/100 across 12 rated trades. Over a 12-month horizon, 91.7% of those trades were profitable, with an average 12-month return of +40.4%.
At the last filing, the largest reported position was 2,660,713 shares of IDYA. Net of sales, the IDYA filings show accumulation of 400,000 shares.
Shares as reported in the last Form 4 for each company; the most recent is from June 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 7, 2016 | CTMX Cytomx Therapeutics, Inc. | Director | Sell | 111,498 | $10.01 | $1,116,289.60 | -2.5% | |
| Jun 3, 2016 | CTMX Cytomx Therapeutics, Inc. | Director | Sell | 59,621 | $10.80 | $644,047.71 | -1.3% | |
| Jun 1, 2016 | CTMX Cytomx Therapeutics, Inc. | Director | Sell | 22,463 | $10.75 | $241,477.25 | -0.5% | |
| May 27, 2016 | CTMX Cytomx Therapeutics, Inc. | Director | Sell | 25,082 | $10.60 | $265,869.20 | -0.6% | |
| May 26, 2016 | CTMX Cytomx Therapeutics, Inc. | Director | Sell | 51,343 | $10.34 | $530,810.53 | -1.1% | |
| May 24, 2016 | CTMX Cytomx Therapeutics, Inc. | - | Sell | 13,253 | $10.09 | $133,735.30 | -0.3% | |
| May 20, 2016 | CTMX Cytomx Therapeutics, Inc. | - | Sell | 8,687 | $10.10 | $87,776.83 | -0.2% |